SequelSEC

Ocean Biomedical, Inc. OCEA

Pharmaceutical Preparations · CIK 0001869974 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2025-03-31
Operating income
-$4.16M
Fiscal year ended 2025-03-31
Free cash flow
Unavailable
Fiscal year ended 2025-03-31

Ocean Biomedical, Inc. (OCEA) reported net income of -$30.72M for the fiscal year ended 2025-03-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Ocean Biomedical, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Ocean Biomedical, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-03-31
RevenueUnavailable
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$4.16M
Net income-$30.72M
Research & development$18.00K
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$4.14M
Selling & marketingUnavailable

Balance

Ocean Biomedical, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-03-31
Cash & equivalentsUnavailable
Total assets$1.58M
Current assets$1.49M
Total liabilities$93.98M
Current liabilities$26.57M
Total equity incl. NCI-$92.40M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$16.39M

Cash flow

Ocean Biomedical, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-03-31
Operating cash flow-$4.05M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flowUnavailable
Net change in cash$258.00K
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

Ocean Biomedical, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-03-31
Free cash flowUnavailable
Gross marginUnavailable
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.06x
Revenue YoY growthUnavailable
Net marginUnavailable
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open OCEA in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2025-05-15View SEC filing
10-K · Filed 2025-04-08View SEC filing
10-Q · Filed 2025-01-13View SEC filing
10-Q · Filed 2024-12-23View SEC filing
10-Q · Filed 2024-12-23View SEC filing
10-K · Filed 2024-11-25View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.